Drug-Induced Anaphylaxis
Carregando...
Citações na Scopus
22
Tipo de produção
article
Data de publicação
2017
Editora
W B SAUNDERS CO-ELSEVIER INC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, v.37, n.4, p.629-0, 2017
Resumo
Drugs are among the main triggers of anaphylaxis, but identification of the culprit drug is frequently difficult. To confirm diagnosis of the causative agent, medical records and clinical history are fundamental. There are a few in vitro tests available in clinical practice, such as serum-specific IgE and basophil activation test. Skin tests are often useful for the diagnosis, although drug challenge is indicated in patients with inconclusive clinical history or to provide safe alternatives. Treatment of anaphylaxis is standard and intramuscular epinephrine is the main agent to prevent morbidity and mortality. Rapid desensitization may be indicated in selected cases.
Palavras-chave
Anaphylaxis, Drug allergy, Adverse drug reactions, Hypersensitivity, Nonsteroidal anti-inflammatory drugs, Epinephrine
Referências
- Aberer W, 2003, ALLERGY, V58, P854, DOI 10.1034/j.1398-9995.2003.00279.x
- Aranda A, 2011, ALLERGY, V66, P247, DOI 10.1111/j.1398-9995.2010.02460.x
- Aun MV, 2014, J ALLER CL IMM-PRACT, V2, P414, DOI 10.1016/j.jaip.2014.03.014
- Aun MV, 2011, ALLERGY ASTHMA PROC, V32, P301, DOI 10.2500/aap.2011.32.3450
- Ayuso P, 2013, CLIN EXP ALLERGY, V43, P1097, DOI 10.1111/cea.12140
- Blatman KSH, 2017, J ALLER CL IMM-PRACT, V5, P587, DOI 10.1016/j.jaip.2017.03.016
- Bonadonna P, 2014, IMMUNOL ALLERGY CLIN, V34, P397, DOI 10.1016/j.iac.2014.01.014
- Bonamichi-Santos R, 2016, CURR PHARM DESIGN, V22, P6870, DOI 10.2174/1381612822666161025154506
- Brennan PJ, 2009, J ALLERGY CLIN IMMUN, V124, P1259, DOI 10.1016/j.jaci.2009.09.009
- Brockow K, 2013, ALLERGY, V68, P702, DOI 10.1111/all.12142
- Caiado J, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0515-3
- Campbell RL, 2015, J ALLER CL IMM-PRACT, V3, P76, DOI 10.1016/j.jaip.2014.06.007
- Castells MC, 2015, J ALLER CL IMM-PRACT, V3, P350, DOI 10.1016/j.jaip.2015.03.015
- Decuyper II, 2017, DRUGS R&D, V17, P265, DOI 10.1007/s40268-017-0176-x
- Demoly P, 2014, ALLERGY, V69, P420, DOI 10.1111/all.12350
- Ensina LF, 2014, J ALLER CL IMM-PRACT, V2, P825, DOI 10.1016/j.jaip.2014.08.016
- Faria E, 2014, J INVEST ALLERG CLIN, V24, P40
- Galvao VR, 2015, J ALLER CL IMM-PRACT, V3, P175, DOI 10.1016/j.jaip.2014.12.006
- Galvao VR, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0452-6
- Gaspar Ângela, 2012, Rev Port Imunoalergologia, V20, P173
- Giavina-Bianchi P, 2017, J ALLER CL IMM-PRACT, V5, P728, DOI 10.1016/j.jaip.2016.11.006
- Giavina-Bianchi P, 2017, J ALLER CL IMM-PRACT, V5, P593, DOI 10.1016/j.jaip.2017.03.015
- Giavina-Bianchi P, 2016, CURR OPIN ALLERGY CL, V16, P323, DOI 10.1097/ACI.0000000000000292
- Giavina-Bianchi P, 2015, CURR TREAT OPTIONS A, V2, P268
- Gonzalez-Estrada A, 2017, ANN ALLERG ASTHMA IM, V118, P80, DOI 10.1016/j.anai.2016.10.025
- Jerschow E, 2014, J ALLERGY CLIN IMMUN, V134, P1318, DOI 10.1016/j.jaci.2014.08.018
- Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591
- Jares EJ, 2015, J ALLER CL IMM-PRACT, V3, P780, DOI 10.1016/j.jaip.2015.05.012
- Karakaya G, 2013, RESP MED, V107, P967, DOI 10.1016/j.rmed.2013.03.014
- Kemp SF, 2011, ANAPHYLAXIS AND HYPERSENSITIVITY REACTIONS, P33, DOI 10.1007/978-1-60327-951-2_3
- Kim YJ, 2014, ALLERGY ASTHMA IMMUN, V6, P156, DOI 10.4168/aair.2014.6.2.156
- Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200
- Kowalski ML, 2011, ALLERGY, V66, P818, DOI 10.1111/j.1398-9995.2011.02557.x
- Krishna MT, 2014, CLIN EXP IMMUNOL, V178, P399, DOI 10.1111/cei.12424
- Kuruvilla M, 2015, IMMUNOL ALLERGY CLIN, V35, P303, DOI 10.1016/j.iac.2015.01.008
- Lee YS, 2017, ACTA ANAESTHESIOL TA
- Leone R, 2005, DRUG SAFETY, V28, P547, DOI 10.2165/00002018-200528060-00006
- Lieberman P, 2011, ANAPHYLAXIS AND HYPERSENSITIVITY REACTIONS, P1, DOI 10.1007/978-1-60327-951-2_1
- Liew WK, 2009, J ALLERGY CLIN IMMUN, V123, P434, DOI 10.1016/j.jaci.2008.10.049
- McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022
- Mertes PM, 2011, J INVEST ALLERG CLIN, V21, P442
- Munoz-Cano R, 2016, J INVEST ALLERG CLIN, V26, P73, DOI 10.18176/jiaci.0046
- Park HK, 2017, ALLERGOL INT
- Picard M, 2017, J ALLER CL IMM-PRACT, V5, P600, DOI 10.1016/j.jaip.2016.12.001
- Picard M, 2016, J ALLERGY CLIN IMMUN, V137, P1154, DOI 10.1016/j.jaci.2015.10.039
- Garcia AP, 2010, J INVEST ALLERG CLIN, V20, P170
- Pumphrey RSH, 2011, ANAPHYLAXIS AND HYPERSENSITIVITY REACTIONS, P13, DOI 10.1007/978-1-60327-951-2_2
- Renaudin JM, 2013, ALLERGY, V68, P929, DOI 10.1111/all.12168
- Ribeiro-Vaz I, 2013, EUR J CLIN PHARMACOL, V69, P673, DOI 10.1007/s00228-012-1376-5
- Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303
- Simon RA, 2017, NSAIDS INCLUDING ASP
- Simons FER, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0080-1
- Simons FER, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-9
- Simons FER, 2011, WORLD ALLERGY ORGAN, V4, P13, DOI 10.1097/WOX.0b013e318211496c
- Sloane D, 2016, J ALLER CL IMM-PRACT, V4, P497, DOI 10.1016/j.jaip.2015.12.019
- Subramanian H, 2016, J ALLERGY CLIN IMMUN, V138, P700, DOI 10.1016/j.jaci.2016.04.051
- Tang MLK, 2009, CURR OPIN ALLERGY CL, V9, P351, DOI 10.1097/ACI.0b013e32832db95a
- Tanno LK, 2017, ALLERGY, V72, P120, DOI 10.1111/all.13006
- Techapornroong M, 2010, ASIAN PAC J ALLERGY, V28, P262
- VanDerKlauw MM, 1996, CLIN EXP ALLERGY, V26, P1355, DOI 10.1046/j.1365-2222.1996.d01-300.x
- Wang DY, 1998, PHARMACOEPIDEM DR S, V7, P269, DOI 10.1002/(SICI)1099-1557(199807/08)7:4<269::AID-PDS366>3.0.CO;2-3
- Yang MS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005750